SPY336.71+4.34 1.31%
DIA278.74+4.32 1.57%
IXIC11,243.74+158.49 1.43%

Citigroup Maintains Buy on Cidara Therapeutics, Lowers Price Target to $5

Citigroup maintains Cidara Therapeutics (NASDAQ:CDTX) with a Buy and lowers the price target from $6 to $5.

Benzinga · 08/26/2020 11:07
Citigroup maintains Cidara Therapeutics (NASDAQ: CDTX) with a Buy and lowers the price target from $6 to $5.